-
Tokuyuki Yoshida
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Yasuo Yoshioka
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio) The Center for Advanced Medical Engineering and Informatics, Osaka University
-
Maho Fujimura
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Hiroyuki Kayamuro
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Kohei Yamashita
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Kazuma Higashisaka
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Ryosuke Nakanishi
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Yuki Morishita
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Hiromi Nabeshi
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Takuya Yamashita
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Masashi Muroi
Research Institute of Pharmaceutical Sciences, Musashino University
-
Kenichi Tanamoto
Research Institute of Pharmaceutical Sciences, Musashino University
-
Kazuya Nagano
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Yasuhiro Abe
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Haruhiko Kamada
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio) The Center for Advanced Medical Engineering and Informatics, Osaka University
-
Yuichi Kawai
Graduate School of Pharmaceutical Sciences, Kobe-Gakuin University
-
Tadanori Mayumi
Graduate School of Pharmaceutical Sciences, Kobe-Gakuin University
-
Norio Itoh
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University
-
Tomoaki Yoshikawa
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio)
-
Shinichi Tsunoda
Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio) The Center for Advanced Medical Engineering and Informatics, Osaka University
-
Yasuo Tsutsumi
Department of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation (NiBio) The Center for Advanced Medical Engineering and Informatics, Osaka University